Ropes & Gray LLP provide a comprehensive life sciences offering, covering matters from licensing and IP disputes to M&A, venture capital and capital markets. The team is particularly adept in regulatory issues relating to human genetic regulation, data privacy and research compliance. Arthur Mok spearheads the practice from New York and San Francisco, with nearly two decades of experience and is frequently sought out by multinational pharmaceutical and biotechnology companies to assist with issues in the greater China region. Eric Wu is well-versed in corporate transactional and governance needs throughout the full life cycle of a company. Katherine Wang excels in regulatory, compliance and enforcement advice, from clinical studies and market access to product manufacturing and promotion, with capabilities extending to cross-border transfers of personal data and biological materials, while Geoffrey Lin is noted for his IP expertise in the pharmaceuticals, biotechnology and healthcare sectors.
Legal 500 Editorial commentary

Key clients

  • ADC Therapeutics
  • Everest Medicines
  • FibroGen
  • Zai Lab Limited
  • Corxel Pharmaceuticals
  • Erasca
  • HilleVax
  • Allorion Therapeutics
  • GlaxoSmithKline
  • SK Biopharmaceuticals
  • HilleVax
  • Allorion Therapeutics
  • GlaxoSmithKline
  • SK Biopharmaceuticals

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

Arthur Mok

Other key lawyers

Eric Wu; Katherine Wang; Geoffrey Lin